🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Oncocytic (Hurthle cell) thyroid cancer (HTC) is a rare diseas...
Status
Not Yet Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2026-09-02
Trial ID
NCT06991738
Treatments Being Tested
This study is a phase 2, open, single-site trial. The primary objective of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-12-18
Trial ID
NCT06121271
Treatments Being Tested
The purpose of this study is to determine if 68Gallium-octreotate and 18Flu...
Status
Completed
Location
Jules Bordet Institute
Start Date
2013-05
Trial ID
NCT01842165
Treatments Being Tested
This phase I trial tests the safety and effectiveness of stereotactic body ...
Status
Recruiting
Location
Emory University Hospital Midtown
Start Date
2025-10-14
Trial ID
NCT07150546
In this study, we want to randomize patients with neuroendocrine neoplasms ...
Status
Recruiting
Location
Aarhus University Hospital, department of Nuclear medicine and PET centre
Start Date
2020-02-01
Trial ID
NCT04917484
Treatments Being Tested
Fibroblast activation protein (FAP) is a cell surface protein that is highl...
Status
Recruiting
Location
UAB Comprehensive Cancer Center
Start Date
2021-07-30
Trial ID
NCT04939610
Treatments Being Tested
This study is the first randomized, open-label, national, multicenter, phas...
Status
Completed
Location
Gustave Roussy
Start Date
2015-02
Trial ID
NCT02230176
Treatments Being Tested
Peptide Receptor Radionuclide Therapy (PRRT) is based on specific somatosta...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2020-03-09
Trial ID
NCT04385992
Treatments Being Tested
This phase II trial compares the effect of retreatment with 177Lu-DOTATATE ...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-01-12
Trial ID
NCT05773274
This is a multicenter, open-label, single-arm study to evaluate the safety ...
Status
Active Not Recruiting
Location
University of Kentucky
Start Date
2022-08-31
Trial ID
NCT04711135
Treatments Being Tested